Par Drugs and Chemicals Limited conducted its 26th Annual General Meeting on September 27, 2025, discussing financial results with a revenue of ₹10,312.38 lakh for FY25, up from ₹9,588.27 lakh in FY24, and a net profit of ₹1,335.79 lakh, down from ₹1,450.10 lakh in the previous year.